Let-7c Governs the Acquisition of Chemo- or Radioresistance and Epithelial-to-Mesenchymal Transition Phenotypes in Docetaxel-Resistant Lung Adenocarcinoma
暂无分享,去创建一个
Bing Feng | Wei De | W. De | Long-Bang Chen | Rui Wang | Guichun Huang | Bing Feng | Rui Wang | Long-Bang Chen | Shi-Yun Cui | Jia-Yuan Huang | Yi-Tian Chen | Hai-Zhu Song | Gui-Chun Huang | Jia-yuan Huang | Hai-zhu Song | Shiyun Cui | Jiayuan Huang | Yi-tian Chen | Long-Bang Chen
[1] Jun Luo,et al. MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth , 2012, PloS one.
[2] Carlos Agustí,et al. MicroRNAs Expressed during Lung Cancer Development Are Expressed in Human Pseudoglandular Lung Embryogenesis , 2009, Oncology.
[3] Kiyoshi Yanagisawa,et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11‐21 in human lung cancer , 2008, Genes, chromosomes & cancer.
[4] Jhi-Joung Wang,et al. Let-7d functions as novel regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. , 2011, Oncology reports.
[5] A. Chang. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. , 2011, Lung cancer.
[6] C. Dinney,et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer , 2009, Cancer and Metastasis Reviews.
[7] Liang-an Chen,et al. microRNAs as tumor inhibitors, oncogenes, biomarkers for drug efficacy and outcome predictors in lung cancer (Review) , 2012, Molecular medicine reports.
[8] J. Minna,et al. Homozygous deletion scanning of the lung cancer genome at a 100‐kb resolution , 2007, Genes, chromosomes & cancer.
[9] Hideo Baba,et al. Epithelial–mesenchymal transition in cancer development and its clinical significance , 2010, Cancer science.
[10] R. Gatti,et al. MicroRNAs: new players in the DNA damage response. , 2011, Journal of molecular cell biology.
[11] W. De,et al. Identification of ING4 (Inhibitor of Growth 4) as a Modulator of Docetaxel Sensitivity in Human Lung Adenocarcinoma , 2012, Molecular medicine.
[12] J. Walling. Chemotherapy for advanced non-small-cell lung cancer. , 1994, Respiratory medicine.
[13] S. Gettinger,et al. A decade of advances in treatment for advanced non-small cell lung cancer. , 2011, Clinics in chest medicine.
[14] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[15] M. Zern,et al. Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations. , 2011, Journal of hepatology.
[16] Y. Doki,et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. , 2010, Journal of hepatology.
[17] J. Mendell,et al. MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.
[18] Feng Bing,et al. Identification of microRNA profiles in docetaxel-resistant human non-small cell lung carcinoma cells (SPC-A1) , 2009, Journal of cellular and molecular medicine.
[19] Nikitina Eg,et al. MicroRNAs and human cancer. , 2012 .
[20] D. Bartel. MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.
[21] B. Monia,et al. Inhibition of Bcl-xL expression sensitizes T-cell acute lymphoblastic leukemia cells to chemotherapeutic drugs. , 2002, Leukemia research.
[22] Ming Sun,et al. Adenovirus-mediated siRNA targeting Bcl-xL inhibits proliferation, reduces invasion and enhances radiosensitivity of human colorectal cancer cells , 2011, World journal of surgical oncology.
[23] Huan Yang,et al. Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancer. , 2005, Current opinion in investigational drugs.
[24] P-C. Yang,et al. MicroRNA in lung cancer , 2010, British Journal of Cancer.
[25] J. Gu,et al. Let‐7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer , 2012, The Journal of pathology.
[26] N. Matsuura,et al. Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. , 2011, The Annals of thoracic surgery.
[27] A. Jemal,et al. Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.
[28] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[29] Sang-Gu Hwang,et al. Bcl‐XL and STAT3 mediate malignant actions of γ‐irradiation in lung cancer cells , 2010, Cancer science.
[30] E. Nikitina,et al. MicroRNAs and human cancer. , 2012, Experimental oncology.
[31] Long-Bang Chen,et al. MicroRNA‐200b reverses chemoresistance of docetaxel‐resistant human lung adenocarcinoma cells by targeting E2F3 , 2012, Cancer.
[32] Huamin Wang,et al. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. , 2009, Cancer research.
[33] De-Pei Liu,et al. MicroRNAs: key participants in gene regulatory networks. , 2003, Current opinion in chemical biology.
[34] Bing Feng,et al. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. , 2012, Cancer letters.
[35] Margaret S. Ebert,et al. Roles for MicroRNAs in Conferring Robustness to Biological Processes , 2012, Cell.
[36] A. Aigner. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs , 2011, Journal of Molecular Medicine.
[37] S. Qiu,et al. Radiation enhances long-term metastasis potential of residual hepatocellular carcinoma in nude mice through TMPRSS4-induced epithelial–mesenchymal transition , 2011, Cancer Gene Therapy.
[38] Alfonso Bellacosa,et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.
[39] A. Pasquinelli,et al. Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation , 2005, Cell.
[40] R. Kim. Unknotting the roles of Bcl-2 and Bcl-xL in cell death. , 2005, Biochemical and biophysical research communications.
[41] Sun-Mi Park,et al. The role of let-7 in cell differentiation and cancer. , 2010, Endocrine-related cancer.
[42] Zhiwei Wang,et al. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. , 2009, Cancer research.